Skip to main content

Table 2 MINORS score for quality assessment of the included studies

From: The prevalence of spontaneous pneumothorax in patients with BHD syndrome: a systematic review and meta-analysis

Study/year

Methodological items

Total

1

2

3

4

5

6

7

8

9

10

11

12

[26]

2

2

2

2

2

2

2

2

2

2

2

2

24

[19]

2

2

2

2

2

2

2

0

2

2

2

2

22

[34]

2

2

2

2

2

2

2

0

0

0

0

0

14

[23]

2

2

2

2

2

2

2

0

2

2

2

2

22

[12]

2

2

2

2

2

2

2

0

0

0

0

0

14

[20]

2

2

2

2

2

2

2

0

0

0

0

0

14

[21]

2

2

2

2

2

2

2

0

0

0

0

0

14

[17]

2

2

2

2

2

2

2

0

0

0

0

0

14

[25]

2

2

2

2

2

2

2

0

0

0

0

0

14

[22]

2

2

2

2

2

2

2

0

0

0

0

0

14

[32]

2

2

2

2

2

2

2

0

0

0

0

0

14

[18]

2

2

2

2

2

2

2

0

0

0

0

0

14

[6]

2

2

2

2

2

2

2

0

2

2

2

2

22

[24]

2

2

2

2

2

2

2

0

0

0

0

0

14

[11]

2

2

2

2

2

2

2

0

0

0

0

0

14

[30]

2

2

2

2

2

2

2

0

0

0

0

0

14

[29]

2

2

2

2

2

2

2

0

0

0

0

0

14

[31]

2

2

2

2

2

2

2

0

0

0

0

0

14

  1. The final score comprises the results of 8 items or 12 items in cases of comparative studies: 1 A clearly stated aim; 2 Inclusion of consecutive patients; 3 Prospective collection of data; 4 Endpoints appropriate to the aim of the study; 5 Unbiased evaluation of the study endpoint; 6 Follow-up period appropriate to the aim of the study; 7 Loss to follow-up less than 5%; 8 Prospective calculation of the study size; 9 An adequate control group; 10 Contemporary groups; 11 Baseline equivalence of groups; 12 Adequate statistical analysis
Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172